Početna › Rak mjehura › Ohio › Cincinnati
Kliničke studije za Rak mjehura u gradu Cincinnati, OH
10 studija za Rak mjehura traži sudionike na lokacijama u gradu Cincinnati i okolici (unutar oko 30 milja). Otvorite studiju da biste vidjeli tko se može priključiti i kako kontaktirati tim studije.
Službeni tekst studije (engleski)
Tražite sudionike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
- Good Samaritan Hospital - Cincinnati, Cincinnati
- Oncology Hematology Care Inc-Kenwood, Cincinnati
- Bethesda North Hospital, Cincinnati
- i još 3
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
U tijeku regrutacijaFaza 2
- TriState Urologic Services PSC Inc. dba The Urology Group ( Site 0122), Cincinnati
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
U tijeku regrutacijaFaza 2
- University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
- University of Cincinnati Cancer Center-West Chester, West Chester · 15 mi udaljenosti
Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
U tijeku regrutacijaFaza 3
- Oncology Hematology Care Clinical Trials, LLC, Fairfield · 15 mi udaljenosti
A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)
U tijeku regrutacijaFaza 3
- TriHealth Cancer Institute-Good Samaritan Hospital ( Site 0822), Cincinnati
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
U tijeku regrutacijaFaza 3
- University of Cincinnati Medical Center, Cincinnati
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
U tijeku regrutacijaFaza 2
- The Urology Group (Solaris), Cincinnati
- University of Cincinnati Cancer Center, Cincinnati
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
U tijeku regrutacijaFaza 1
- University of Cincinnati Medical Center (UCMC), Cincinnati
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
U tijeku regrutacijaFaza 1/2
- University of Cincinnati Medical Center, Cincinnati
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
U tijeku regrutacijaOpažajna studija
- Massive Bio SYNERGY-AI site, Cincinnati
Studije za Rak mjehura u drugim gradovima
- New York City, NY35 studija
- Nashville, TN31 studija
- Houston, TX31 studija
- Dallas, TX27 studija
- Boston, MA26 studija
- Washington, DC26 studija
- Los Angeles, CA24 studija
- Baltimore, MD24 studija
- St. Louis, MO22 studija
- Philadelphia, PA21 studija
- Seattle, WA21 studija
- Edison, NJ21 studija
Ostale studije u gradu Cincinnati
- Nemikrocelularni karcinom pluća35 studija
- Rak (sve vrste)27 studija
- Rak dojke25 studija
- Srčano zatajenje24 studija
- Kolorektalni rak21 studija
- Akutna mijeloična leukemija20 studija
- Metastatski karcinom20 studija
- Rak jajnika19 studija
- Rak pluća19 studija
- Debljina19 studija
- Rak prostate18 studija
- Multipli mijelom17 studija
Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.